← Open Payments lookup

JAMES EYERMAN: Open Payments

NPI 1588615843 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$13,244 in 23 payments from 6 companies in 2025. Trend: 2023 $1,341 · 2024 $13,807 · 2025 $13,244

Speaker / faculty: $12,177Food & beverage: $966Education: $101
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.8$12,513
E.R. Squibb & Sons, L.L.C.7$213
Neurocrine BioSciences, Inc.2$165
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$151
Alkermes, Inc.1$128
Janssen Pharmaceuticals, Inc2$73

Products named: UZEDY, COBENFY, INGREZZA, CAPLYTA, LYBALVI, INVEGA SUSTENNA.

Industry payments across CA — which companies pay providers there.